Lv61
1690 积分 2023-09-01 加入
Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials
5小时前
已完结
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial
1个月前
已关闭
Diagnostic value of IL-22, IL-23, and IL-17 for NK/T cell lymphoma
2个月前
已关闭
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
4个月前
已完结
Lebrikizumab Treatment in Adults with Asthma
4个月前
已关闭
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
4个月前
已完结
TL1A: A model for a precision medicine approach in the treatment of Crohn’s disease and Ulcerative colitis
5个月前
已完结
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
5个月前
已完结
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
5个月前
已完结
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
5个月前
已完结
皖公网安备34019202002308
